Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

THERMO FISHER SCIENTIFIC

(TMO)
  Report
Delayed Nyse  -  04:00 2022-09-27 pm EDT
508.66 USD   -1.10%
09/22Thermo Fisher Scientific Partners with Pennsylvania Biotechnology Center to Support Life Sciences Growth in Philadelphia
AQ
09/21Thermo Fisher Scientific Opens Biomanufacturing Facility in Massachusetts
MT
09/20Thermo Fisher Scientific : Invests $160 Million to Expand Bioproduction Capacity in Greater Boston
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific Inc. Unveils Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam, New Connected and Automated Microscope

08/01/2022 | 08:00am EDT

Thermo Fisher Scientific Inc. unveiled the Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), a new connected and automated microscope designed to advance the pace of cryo-electron tomography (cryo-ET) research. Cryo-ET makes it possible to study how proteins and other molecules operate together in a cellular context, at resolutions unsurpassed by other microscopy techniques, and has enormous potential for cell biology research, including the study of infectious disease, neurodegenerative disease, and other globally impactful structural biology applications. However, the process of preparing optimal samples for cryo-ET is still time-consuming and complex.

The Arctis Cryo-PFIB helps users address these challenges with advanced automation and new connectivity capabilities within the workflow, significantly increasing throughput compared to other commercially available solutions for fast, reproducible production of samples for cryo-ET. The system is designed to provide high-quality samples with consistent thickness while minimizing sample contamination risks. Users will benefit from integrated correlative microscopy, dedicated Plasma FIB technology, advanced automation and new connectivity capabilities, including simplified sample loading and transfer.

Highlights include: Integrated correlative light and electron microscopy (CLEM) for quick targeting of the area of biological interest. Plasma FIB technology for rapid removal of large sample volumes and quick access to areas of biological interest. Automation capabilities to simplify sample preparation and enable remote operation, allowing for long automated runs, reproducible results and higher throughput compared to current gallium-based cryo-FIB solutions.

Connectivity in the workflow for simplifying the transfer of samples to the Thermo Scientific Krios or Glacios Cryo-TEMs. The Arctis Cryo-PFIB comes with Thermo Fisher's Autoloader which robotically loads cassettes with up to 12 grids. New dedicated TomoGrids are designed to achieve optimal alignment of the lamella to the TEM tilt axis.


© S&P Capital IQ 2022
All news about THERMO FISHER SCIENTIFIC
09/22Thermo Fisher Scientific Partners with Pennsylvania Biotechnology Center to Support Lif..
AQ
09/21Thermo Fisher Scientific Opens Biomanufacturing Facility in Massachusetts
MT
09/20Thermo Fisher Scientific : Invests $160 Million to Expand Bioproduction Capacity in Greate..
PU
09/14THERMO FISHER SCIENTIFIC : Ex-dividend day for
FA
09/13Thermo Fisher Scientific Collaborates with Taiwan Precision Medicine Initiative to Geno..
CI
09/12Barclays Cuts Thermo Fisher Scientific's Price Target to $595 From $685, Keeps Overweig..
MT
09/12Transcript : Thermo Fisher Scientific Inc. Presents at Morgan Stanley 20th An..
CI
09/12Thermo Fisher Scientific Certifies Applies Biosystems QuantStudio 7 Pro Dx Real-Time PC..
CI
09/07Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference
BU
08/30Thermo Fisher Scientific Launches CE-IVD Next-Generation Sequencing Test and Analysis S..
AQ
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 43 199 M - -
Net income 2022 6 924 M - -
Net Debt 2022 24 596 M - -
P/E ratio 2022 29,1x
Yield 2022 0,23%
Capitalization 199 B 199 B -
EV / Sales 2022 5,18x
EV / Sales 2023 4,97x
Nbr of Employees 130 000
Free-Float 88,7%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 508,66 $
Average target price 658,24 $
Spread / Average Target 29,4%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
THERMO FISHER SCIENTIFIC-21.95%201 501
DANAHER CORPORATION-20.17%191 071
INTUITIVE SURGICAL, INC.-47.70%67 112
BOSTON SCIENTIFIC CORPORATION-8.43%54 917
EDWARDS LIFESCIENCES CORPORATION-35.48%51 821
SIEMENS HEALTHINEERS AG-36.49%45 093